Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
- Authors: Antsiferov M.B1, Dorofeeva L.G1
-
Affiliations:
- Issue: No 16 (2012)
- Pages: 98-103
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279941
- ID: 279941
Cite item
Open Access
Access granted
Abstract
The results of the observation program, which was aimed to evaluation of the efficacy and safety of use of gliclazide MR (Diabeton MR) 60 mg for transfering the patients with type 2 diabetes mellitus (DM2) from Diabeton MR 30 mg, and dose titration of Diabeton CF 60 mg for the achievement of target glycemic control in the absence of the previous antihyperglycemic therapy are analyzed. The observation program showed that the use of Diabeton MR in optimal doses with sequential titration improves glycemic control in combination with the safety of therapy.
Full Text
References
- Дедов И.И., Шестакова М.В., Аметов А.С., Анциферов М.Б. и др. Проект "Консенсус совета экспертов Российской ассоциации эндокринологов (РАЭ) по инициации и интенсификации сахароснижающей терапии СД 2 типа" // Сахарный диабет 2011. № 1. С. 98-108.
- Nathan D.M., Buse J.B., Davidson M.B., et al. American Diabetes Association; European Association for the Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and andjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
- Aguilar-Bryan L., Nichols C.G., Wechsler S.F. Cloning of the в-cell high affinity sulfonylurea receptor: regulator of insulin secretion. Science 1995;268:423-26.
- Российская ассоциация эндокринологов "Российская ассоциация эндокринологов о начале применения Диабетона МВ 60 мг"// Сахарный диабет 2011. № 2. С. 126.
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под редакцией И.И. Дедова, М.В. Шестаковой. 5-ы выпуск. 2011.
- Patei A., MacMahon S., Chalmers J., et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
Supplementary files
